Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Openai CEO SAM Altman is doubling down on Retro Biocians, a biotech startup in San Francisco that wants people to live 10 years longer than what a healthy human lifespan would.
Altman earlier given Retro Biosciiences’ whole seed round of $180 million. Now the startup is raising a $1 billion series round for Altman’s merger, Financial times report.
Retro biotorrents, which recently plans to begin trials for drugs targeting diseases such as Alzheimer’s developed a model With Openai to convert permanent cells into stem cells.
CEO Joe Betts-Lacroix said he wants to move quickly by discovering and developing a drug in the 2020s.
The startup joins other major billionaire-backed longevity efforts, including altos labs started it Jeff Bezos and Commonwealth Biotechnology, $3 billion in 2022 supported by both Bezos and Peter Thiel.
